You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 3, March 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Influence of Seizure Type on the Efficacy of Plasma Concentrations of Phenytoin, Phenobarbital, and Carbamazepine

Dieter Schmidt, MD; Ilse Einicke; Ferdinand Haenel, MD

Arch Neurol. 1986;43(3):263-265.


Abstract

• Plasma concentrations of phenytoin, phenobarbital, or carbamazepine were monitored prospectively during successful single-drug therapy in 78 patients who had various types of epileptic seizures. Mean plasma concentrations necessary for complete control of tonic-clonic seizures alone were as follows: phenytoin, 14µg/mL(n = 28); phenobarbital, 18 µg/mL (n = 10); and carbamazepine, 5.5 µg/mL (n = 2). Epilepsy with simple or complex partial seizures alone or together with tonic-clonic seizures was completely controlled at the following plasma concentrations: phenytoin, 23 µg/mL (n = 25); phenobarbital, 37 µg/mL (n = 5); and carbamazepine, 7 µg/mL (n = 7). Higher plasma concentrations of phenytoin, phenobarbital, and carbamazepine are necessary for control in epilepsy with simple or complex partial seizures compared with epilepsy with tonic-clonic seizures alone. The efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine varies with the type of seizure.



Author Affiliations

From the Grosshadern Clinic, Ludwing-Maximilians University, Department of Neurology, Munich.


Footnotes

Accepted for publication Jan 29, 1985.

Reprint requests to Klinikum Grosshadern, Ludwing-Maximilians-Universität, Department of Neurology, Marchioninistrasse 15, 8000 München 70, West Germany (Dr Schmidt).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten
Arroyo and Sander
Neurology 1999;53:1170-1170.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.